Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2423817 | 0.82 | KDM4E (0.47) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL162807 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL3809367 | 0.81 | CYP1A2 (0.53) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL4704967 | 0.80 | ALDH1A1 (0.46) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL28509975 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL20595215 | 0.79 | KDM4E (0.45) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL38659549 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL19358702 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDHTTRECQL | |
| Hydrochloric Acid SCHEMBL5741762 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDHTTRECQL | |
| SCHEMBL1079256 | 0.78 | KDM4E (0.46) | ALDH1A1KDM4EHPGDHTTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119230972-A | Mixed electrolyte containing amino, imidazolyl and sulfonic acid groups, and preparation method and application thereof | 南方科技大学 | 2024-12-31 | — | — | CN | claimed |
| WO-2026107489-A1 | SOLUBLE FORMULATIONS | Design Therapeutics, Inc. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2025076181-A1 | METHODS AND COMPOUNDS FOR MODULATING HUNTINGTON'S DISEASE | Design Therapeutics, Inc. (US) | 2025-04-10 | — | — | WO | disclosed |
| CN-119230972-A | Mixed electrolyte containing amino, imidazolyl and sulfonic acid groups, and preparation method and application thereof | 南方科技大学 | 2024-12-31 | — | — | CN | disclosed |
| US-20240425461-A1 | PREPARATION PROCESS OF INTERMEDIATE, SYNTHESIS PROCESS OF AMINO IMIDAZOLE CARBOXYLATE ESTER AND HPLC PURITY MEASURE METHOD | ASCENTAWITS PHARMACEUTICALS, LTD. (CN) | 2024-12-26 | — | — | US | disclosed |
| CN-118063491-A | Imide catalyst auxiliary agent, polyimide film and preparation method | 中国科学院化学研究所 | 2024-05-24 | — | — | CN | disclosed |
| CN-116789558-A | Preparation method of intermediate, synthesis method of amino imidazole carboxylate and HPLC (high performance liquid chromatography) purity detection method | 深圳艾欣达伟医药科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-1732901-B1 | ANTIVIRAL 4-AMINOCARBONYLAMINO-SUBSTITUTED IMIDAZOLE COMPOUND | AICURIS GMBH & CO KG (DE) | 2011-11-02 | — | — | EP | disclosed |
| EP-0581502-B1 | Antibiotic carbapenem compounds | ZENECA LTD (GB) | 1998-10-21 | — | — | EP | disclosed |
| US-5527793-A | Antibiotic carbapenem compounds | ZENECA LIMITED (GB) | 1996-06-18 | — | — | US | disclosed |
| EP-0581502-A1 | Antibiotic carbapenem compounds | ZENECA LIMITED (GB) | 1994-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425461-A1 | PREPARATION PROCESS OF INTERMEDIATE, SYNTHESIS PROCESS OF AMINO IMIDAZOLE CARBOXYLATE ESTER AND HPLC PURITY MEASURE METHOD | ABAT, ALDH7A1, IDH2 | ALDH1A1 109/4885KDM4E 260/4885HPGD 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.